The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1199
January 3, 2005
View Complete Issue         Table of Contents 2019 
Acamprosate (Campral) for Alcoholism
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
Acamprosate (Campral) for Alcoholism
January 3, 2005 (Issue: 1199)
Acamprosate calcium (Campral - Forest) is now being marketed for oral use to maintain abstinence from alcohol. It has been used in France and other countries since 1989.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this article:
Title: Acamprosate (Campral) for Alcoholism
Article code: 1199a
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.